Three Arch Management IV, L.L.C. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Three Arch Management IV, L.L.C..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Three Arch Management IV, L.L.C.. Three Arch Management IV, L.L.C. is 10% Owner in NORTH AMERICAN SCIENTIFIC INC ($NASI) and Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and in NEVRO CORP ($NVRO).
Latest Insider Trading Transactions of Three Arch Management IV, L.L.C.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, CNCE, NVRO, NASI
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 20 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Sell | S | 12.29 | 5,400 | 66,366 | 12,301 | 17.7 K to 12.3 K (-30.51 %) |
| Nov 20 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Sell | S | 12.29 | 244,600 | 3,006,134 | 557,126 | 801.7 K to 557.1 K (-30.51 %) |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 4,506 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 15,069 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 28,090 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 204,076 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 682,475 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Option Exercise | C | 0.00 | 1,272,187 | 0 | 0 | ||
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 4,506 | 0 | 47,755 | 43.2 K to 47.8 K (+10.42 %) | |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 15,069 | 0 | 43,249 | 28.2 K to 43.2 K (+53.47 %) | |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 28,090 | 0 | 28,180 | 90 to 28.2 K (+31,211.11 %) | |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 204,076 | 0 | 2,162,814 | 2 M to 2.2 M (+10.42 %) | |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 682,475 | 0 | 1,958,738 | 1.3 M to 2 M (+53.47 %) | |
| Nov 12 2014 | NVRO | NEVRO CORP | Three Arch Management IV, L.L. ... | Buy | C | 0.00 | 1,272,187 | 0 | 1,276,263 | 4.1 K to 1.3 M (+31,211.65 %) | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 391,359 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 1,956,794 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 1,467,595 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 8,641 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 43,206 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Option Exercise | C | 0.00 | 32,405 | 0 | 0 | |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | P | 14.00 | 101,264 | 1,417,696 | 801,726 | 700.5 K to 801.7 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | P | 14.00 | 2,236 | 31,304 | 17,701 | 15.5 K to 17.7 K (+14.46 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 69,267 | 0 | 700,462 | 631.2 K to 700.5 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 346,335 | 0 | 631,195 | 284.9 K to 631.2 K (+121.58 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 259,751 | 0 | 284,860 | 25.1 K to 284.9 K (+1,034.49 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 1,529 | 0 | 15,465 | 13.9 K to 15.5 K (+10.97 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 7,647 | 0 | 13,936 | 6.3 K to 13.9 K (+121.59 %) |
| Feb 21 2014 | CNCE | CONCERT PHARMACEUT ... | Three Arch Management IV, L.L. ... | Director | Buy | C | 0.00 | 5,735 | 0 | 6,289 | 554 to 6.3 K (+1,035.20 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 2,562 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | S | 5.00 | 9,557 | 47,785 | 2,562 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 12,119 | 0 | 12,119 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 12,119 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | J | 0.00 | 12,119 | 0 | 12,119 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 56 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | S | 5.00 | 211 | 1,055 | 56 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 267 | 0 | 267 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 267 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | J | 0.00 | 267 | 0 | 267 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 24,878 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | S | 5.00 | 92,783 | 463,915 | 24,878 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 117,661 | 0 | 117,661 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 117,661 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 549 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | S | 5.00 | 2,048 | 10,240 | 549 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 2,597 | 0 | 2,597 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | X | 0.00 | 2,597 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 857,241 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 18,928 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 321,036 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 7,088 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 440,278 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | C | 0.00 | 9,721 | 0 | 0 | |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | P | 5.00 | 1,261,927 | 6,309,635 | 3,749,918 | 2.5 M to 3.7 M (+50.72 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | P | 5.00 | 27,863 | 139,315 | 82,795 | 54.9 K to 82.8 K (+50.72 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 27,440 | 0 | 2,487,991 | 2.5 M to 2.5 M (+1.12 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 605 | 0 | 54,932 | 54.3 K to 54.9 K (+1.11 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 520,510 | 0 | 2,460,551 | 1.9 M to 2.5 M (+26.83 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 11,492 | 0 | 54,327 | 42.8 K to 54.3 K (+26.83 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 857,241 | 0 | 1,940,041 | 1.1 M to 1.9 M (+79.17 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 18,928 | 0 | 42,835 | 23.9 K to 42.8 K (+79.17 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 481,465 | 0 | 1,082,800 | 601.3 K to 1.1 M (+80.07 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 10,630 | 0 | 23,907 | 13.3 K to 23.9 K (+80.06 %) |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 601,335 | 0 | 601,335 | 0 to 601.3 K |
| Feb 18 2011 | ACRX | ACELRX PHARMACEUTI ... | Three Arch Management IV, L.L. ... | 10% Owner | Buy | C | 0.00 | 13,277 | 0 | 13,277 | 0 to 13.3 K |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.39 | 27,779 | 10,834 | 27,779 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.39 | 587,605 | 229,166 | 587,605 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.39 | 8,862 | 3,456 | 8,862 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.39 | 401,393 | 156,543 | 401,393 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.25 | 55,051 | 13,543 | 55,051 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.25 | 1,164,462 | 286,458 | 1,164,462 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.25 | 17,564 | 4,321 | 17,564 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Option Exercise | A | 0.25 | 795,445 | 195,679 | 795,445 | |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Grant | A | 0.25 | 1,101,019 | 270,851 | 1,239,739 | 138.7 K to 1.2 M (+793.70 %) |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Grant | A | 0.25 | 23,289,233 | 5,729,151 | 26,223,495 | 2.9 M to 26.2 M (+793.70 %) |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Grant | A | 0.25 | 351,270 | 86,412 | 395,528 | 44.3 K to 395.5 K (+793.69 %) |
| Jan 28 2008 | NASI | NORTH AMERICAN SCI ... | Three Arch Management IV, L.L. ... | 10% Owner | Grant | A | 0.25 | 15,908,898 | 3,913,589 | 17,913,296 | 2 M to 17.9 M (+793.70 %) |
Page: 1